Project Grant HT94252410554
Award Date
6/15/24
Completion Date
6/14/27
Dollars Obligated
$384K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The Sloan-Kettering Institute for Cancer Research was awarded a $1,197,158 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the early detection of melanoma using generalized and reliable AI techniques. The grant term runs from June 15, 2024 to June 14, 2027. The research involves collaboration between investigators at Sloan-Kettering, Northeastern University, Melanoma Institute Australia, and Fundació de...
This federal Project Grant award of $2,808,108.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Sloan-Kettering Institute for Cancer Research to investigate the role of clonal hematopoiesis in therapeutic resistance and metastatic relapse in breast cancer. The award period extends from March 1, 2024 to February 29, 2028. Through this funding, the Sloan-Kettering Institute will explore the...
The federal Project Grant award of $924,001.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the Sloan-Kettering Institute for Cancer Research to investigate the cellular and molecular origins of non-small cell lung cancer (NSCLC) brain metastasis. The research aims to enhance understanding of the mechanisms driving NSCLC brain metastasis, with the goal of developing innovative therapeutic...
The Sloan-Kettering Institute for Cancer Research was awarded a $906,740 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop an application for following images of nevi (moles) to detect melanoma. The project will be conducted over a 3-year period from August 1, 2023 to July 31, 2026. Through this federal grant, the Sloan-Kettering Institute, a non-profit research organization, will focus on innovative and impactful...
This federal Project Grant award for $704,000.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Sloan-Kettering Institute for Cancer Research in New York, NY. The research aims to investigate the role of the NF-I/A transcription factor in regulating fatty acid metabolism in kidney cancer. This multi-year project will run from September 1, 2024 to August 31, 2028. As the prime grantee, the Sloan-Kettering...
The project grant award of $880,000 is funded by the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant is awarded to the Sloan-Kettering Institute for Cancer Research to conduct research on using interferon E as a tumor suppressor and potential therapeutic for pancreatic cancer. The project will take place over a 3-year period from September 1, 2024 to August 31, 2027. As a leading comprehensive cancer...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
Sloan-Kettering Institute For Cancer Research was awarded a $845,789 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2023 to June 30, 2026. The grant will support research to discover biomarkers and address outcome disparities for prostate cancer through exploiting real-world clinical genomic data. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise...
The Defense Health Agency awarded a $1,108,654 Project Grant to the Sloan-Kettering Institute for Cancer Research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 30, 2025, will fund research to accelerate global research for relapsed or refractory extracranial malignant germ cell tumors. The Sloan-Kettering Institute, a leading nonprofit cancer research institution, will leverage its extensive capabilities in cancer biology, genomics,...